Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Assets Average (2016 - 2026)

Champions Oncology has reported Assets Average over the past 16 years, most recently at $29.3 million for Q1 2026.

  • For Q1 2026, Assets Average rose 4.91% year-over-year to $29.3 million; the TTM value through Jan 2026 reached $29.3 million, up 4.91%, while the annual FY2025 figure was $29.2 million, 3.25% down from the prior year.
  • Assets Average for Q1 2026 was $29.3 million at Champions Oncology, down from $30.4 million in the prior quarter.
  • Over five years, Assets Average peaked at $36.3 million in Q1 2023 and troughed at $25.1 million in Q4 2024.
  • A 5-year average of $30.8 million and a median of $31.4 million in 2022 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: skyrocketed 30.48% in 2022 and later decreased 24.9% in 2024.
  • Year by year, Assets Average stood at $35.4 million in 2022, then dropped by 17.74% to $29.1 million in 2023, then fell by 13.79% to $25.1 million in 2024, then increased by 21.0% to $30.4 million in 2025, then dropped by 3.46% to $29.3 million in 2026.
  • Business Quant data shows Assets Average for CSBR at $29.3 million in Q1 2026, $30.4 million in Q4 2025, and $31.4 million in Q3 2025.